| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RC Group Lancet (London, England) 397 (10285), 1637, 2021 | 1796 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RC Group, PW Horby, M Mafham, L Peto, M Campbell, G Pessoa-Amorim, ... Medrxiv, 2021.06. 15.21258542, 2021 | 321* | 2021 |
| Patients' perspective of haemodialysis-associated symptoms B Caplin, S Kumar, A Davenport Nephrology Dialysis Transplantation 26 (8), 2656-2663, 2011 | 278 | 2011 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 252 | 2022 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 251 | 2022 |
| Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group The Lancet Respiratory Medicine 9 (12), 1419-1426, 2021 | 150 | 2021 |
| Galactosylation of IgA1 is associated with common variation in C1GALT1 DP Gale, K Molyneux, D Wimbury, P Higgins, AP Levine, B Caplin, ... Journal of the American Society of Nephrology 28 (7), 2158-2166, 2017 | 133 | 2017 |
| Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors A Tanna, L Guarino, FWK Tam, B Rodriquez-Cubillo, JB Levy, TD Cairns, ... Nephrology Dialysis Transplantation 30 (7), 1185-1192, 2015 | 129 | 2015 |
| Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators? B Caplin, J Leiper Arteriosclerosis, thrombosis, and vascular biology 32 (6), 1343-1353, 2012 | 112 | 2012 |
| What do epidemiological studies tell us about chronic kidney disease of undetermined cause in Meso-America? A systematic review and meta-analysis M Gonzalez-Quiroz, N Pearce, B Caplin, D Nitsch Clinical kidney journal 11 (4), 496-506, 2018 | 100 | 2018 |
| Alanine-glyoxylate aminotransferase-2 metabolizes endogenous methylarginines, regulates NO, and controls blood pressure B Caplin, Z Wang, A Slaviero, J Tomlinson, L Dowsett, M Delahaye, ... Arteriosclerosis, thrombosis, and vascular biology 32 (12), 2892-2900, 2012 | 92 | 2012 |
| Decline in kidney function among apparently healthy young adults at risk of Mesoamerican nephropathy M Gonzalez-Quiroz, ET Smpokou, RJ Silverwood, A Camacho, D Faber, ... Journal of the American Society of Nephrology 29 (8), 2200-2212, 2018 | 88 | 2018 |
| Prevalence and risk factors for impaired kidney function in the district of Anuradhapura, Sri Lanka: a cross-sectional population-representative survey in those at risk of … T Ruwanpathirana, S Senanayake, N Gunawardana, A Munasinghe, ... BMC public health 19, 1-11, 2019 | 69 | 2019 |
| The International Society of Nephrology’s International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology: report of the working group on approaches to … B Caplin, CW Yang, S Anand, A Levin, M Madero, R Saran, S Jayasinghe, ... Kidney international 95 (1), 4-10, 2019 | 65 | 2019 |
| International collaboration for the epidemiology of eGFR in low and middle income populations-rationale and core protocol for the disadvantaged populations eGFR epidemiology … B Caplin, K Jakobsson, J Glaser, D Nitsch, V Jha, A Singh, ... BMC nephrology 18, 1-8, 2017 | 65 | 2017 |
| Association of serum calprotectin (S100A8/A9) level with disease relapse in proteinase 3–antineutrophil cytoplasmic antibody–associated vasculitis RJ Pepper, JB Draibe, B Caplin, FC Fervenza, GS Hoffman, ... Arthritis & Rheumatology 69 (1), 185-193, 2017 | 61 | 2017 |
| Prevalence of and risk factors for chronic kidney disease of unknown aetiology in India: secondary data analysis of three population-based cross-sectional studies C O’Callaghan-Gordo, R Shivashankar, S Anand, S Ghosh, J Glaser, ... BMJ open 9 (3), e023353, 2019 | 57 | 2019 |
| Let’s take the heat out of the CKDu debate: more evidence is needed N Pearce, B Caplin Occupational and environmental medicine 76 (6), 357-359, 2019 | 56 | 2019 |
| How do primary care doctors in England and Wales code and manage people with chronic kidney disease? Results from the National Chronic Kidney Disease Audit LG Kim, F Cleary, DC Wheeler, B Caplin, D Nitsch, SA Hull, ... Nephrology Dialysis Transplantation 33 (8), 1373-1379, 2018 | 53 | 2018 |
| Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsis S Lambden, P Kelly, B Ahmetaj-Shala, Z Wang, B Lee, M Nandi, ... Arteriosclerosis, Thrombosis, and Vascular Biology 35 (6), 1382-1392, 2015 | 52 | 2015 |
